Search

The EMA is offering scientists free advice on the development of therapeutics to treat COVID-19.

Sitting Down With... Stephen Tindal, Director, Science & Technology at Catalent Pharma Solutions, to discuss his career in troubleshooting.

Continuous wet granulation and drying have long been a hot topic in pharmaceutical research and development (R&D) and industry.

Particle size reduction is a key process in laboratories and small scale manufacturing, right through to full size production.

Cambrex is the leading small molecule company that provides drug substance, drug product and analytical services across the entire drug lifecycle.

The development of a CMV vaccine has been 50 years in the making.

Novosteo has developed a targeted drug combination to help accelerate the repair of bone fractures.

Novel compounds could be effective in treating brain-eating amoeba.

Downstream processing is responsible for up to 80 percent of the entire production costs of biotherapeutics.

Catalent’s Better Treatments by Design™ service aims to combine the needs of innovators, prescribers, and patients to create superior products.